Trial Profile
A Randomized Controlled Study on the Second - level Prevention of Dabigatran and Warfarin in Atrial Fibrillation Associated Ischemic Stroke / TIA Acute Phase
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 17 Jul 2017 New trial record